Structuring of a Lung Cancer Screening Program Including Clinical, Radiological and Biological Phenotyping Useful for the Development of Individualized Risk Prediction Tools: PREVALUNG ETOILE
Conditions: Smoking-related Pathology; Atheroma; Chronic Bronchitis; Non-progressive Cancer > 5 Years; Lung Cancer Interventions: Device: thoracic scan Low dose; Biological: BLOOD SAMPLE; Biological: FECES SAMPLE Sponsor: Assistance Publique Hopitaux De Marseille Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2022 Category: Research Source Type: clinical trials